Science Applications (0V9N) Ratios
Science Applications Ratios
GB:0V9N's free cash flow for Q2 2027 was $131.00M. For the 2027 fiscal year, GB:0V9N's free cash flow was decreased by $-15.00M and operating cash flow was $146.00M. See a summary of the company’s cash flow.
| Ratios | Jan 26 | Jan 25 | Jan 24 | Jan 23 | Jan 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.20 | 0.83 | 0.98 | 1.06 | 0.93 |
| Quick Ratio | 1.20 | 0.83 | 0.97 | 0.93 | 0.83 |
| Cash Ratio | 0.19 | 0.04 | 0.08 | 0.10 | 0.08 |
| Solvency Ratio | 0.13 | 0.14 | 0.18 | 0.12 | 0.11 |
| Operating Cash Flow Ratio | 0.62 | 0.35 | 0.34 | 0.47 | 0.38 |
| Short-Term Operating Cash Flow Coverage | 15.22 | 1.58 | 5.14 | 17.16 | 3.50 |
| Net Current Asset Value | $ -2.67B | $ -2.52B | $ -2.40B | $ -2.64B | $ -2.85B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.51 | 0.46 | 0.42 | 0.46 | 0.47 |
| Debt-to-Equity Ratio | 1.80 | 1.52 | 1.26 | 1.49 | 1.67 |
| Debt-to-Capital Ratio | 0.64 | 0.60 | 0.56 | 0.60 | 0.63 |
| Long-Term Debt-to-Capital Ratio | 0.62 | 0.55 | 0.53 | 0.58 | 0.59 |
| Financial Leverage Ratio | 3.57 | 3.33 | 2.98 | 3.27 | 3.55 |
| Debt Service Coverage Ratio | 3.67 | 1.42 | 3.75 | 3.83 | 2.17 |
| Interest Coverage Ratio | 3.88 | 3.85 | 6.17 | 4.17 | 4.40 |
| Debt to Market Cap | 0.53 | 0.41 | 0.31 | 0.41 | 0.53 |
| Interest Debt Per Share | 61.36 | 50.56 | 44.56 | 47.85 | 48.87 |
| Net Debt to EBITDA | 3.82 | 3.41 | 2.44 | 3.72 | 4.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 12.10% | 11.93% | 11.71% | 11.53% | 11.62% |
| EBIT Margin | 7.05% | 7.30% | 9.94% | 6.40% | 6.26% |
| EBITDA Margin | 9.10% | 9.17% | 11.85% | 8.44% | 8.49% |
| Operating Profit Margin | 7.22% | 7.21% | 9.95% | 6.50% | 6.25% |
| Pretax Profit Margin | 5.19% | 5.43% | 8.33% | 4.87% | 4.84% |
| Net Profit Margin | 4.93% | 4.84% | 6.41% | 3.89% | 3.75% |
| Continuous Operations Profit Margin | 4.93% | 4.84% | 6.41% | 3.93% | 3.77% |
| Net Income Per EBT | 94.96% | 89.16% | 76.94% | 80.00% | 77.37% |
| EBT Per EBIT | 71.95% | 75.32% | 83.67% | 74.85% | 77.49% |
| Return on Assets (ROA) | 6.69% | 6.90% | 8.98% | 5.41% | 4.82% |
| Return on Equity (ROE) | 23.87% | 22.95% | 26.72% | 17.71% | 17.11% |
| Return on Capital Employed (ROCE) | 11.99% | 14.00% | 17.83% | 11.34% | 10.51% |
| Return on Invested Capital (ROIC) | 11.28% | 11.54% | 13.47% | 8.45% | 7.93% |
| Return on Tangible Assets | 21.71% | 22.40% | 30.40% | 18.48% | 16.28% |
| Earnings Yield | 7.60% | 6.67% | 7.04% | 5.23% | 5.86% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.51 | 7.48 | 8.14 | 8.23 | 7.28 |
| Payables Turnover | 12.77 | 10.44 | 11.59 | 10.92 | 10.68 |
| Inventory Turnover | 0.00 | 0.00 | 2190.67 | 44.84 | 46.02 |
| Fixed Asset Turnover | 23.97 | 27.91 | 30.63 | 30.82 | 23.93 |
| Asset Turnover | 1.36 | 1.43 | 1.40 | 1.39 | 1.29 |
| Working Capital Turnover Ratio | -322.76 | -55.61 | 338.36 | -856.00 | -197.17 |
| Cash Conversion Cycle | 14.28 | 13.84 | 13.49 | 19.07 | 23.85 |
| Days of Sales Outstanding | 42.87 | 48.80 | 44.82 | 44.35 | 50.10 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.17 | 8.14 | 7.93 |
| Days of Payables Outstanding | 28.59 | 34.97 | 31.49 | 33.42 | 34.18 |
| Operating Cycle | 42.87 | 48.80 | 44.98 | 52.49 | 58.04 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 13.15 | 9.86 | 7.46 | 9.62 | 8.99 |
| Free Cash Flow Per Share | 12.46 | 9.14 | 6.95 | 9.17 | 8.37 |
| Dividend Paid and CapEx Coverage Ratio | 5.97 | 4.45 | 3.74 | 4.93 | 4.25 |
| Capital Expenditure Coverage Ratio | 19.03 | 13.72 | 14.67 | 21.28 | 14.39 |
| Operating Cash Flow Coverage Ratio | 0.23 | 0.21 | 0.18 | 0.21 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.07 | 0.05 | 0.07 | 0.07 |
| Free Cash Flow Yield | 12.25% | 8.44% | 5.44% | 8.83% | 10.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 13.16 | 14.98 | 14.21 | 19.13 | 17.06 |
| Price-to-Sales (P/S) Ratio | 0.65 | 0.73 | 0.91 | 0.74 | 0.64 |
| Price-to-Book (P/B) Ratio | 3.14 | 3.44 | 3.80 | 3.39 | 2.92 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.17 | 11.84 | 18.37 | 11.32 | 9.80 |
| Price-to-Operating Cash Flow Ratio | 7.74 | 10.98 | 17.12 | 10.79 | 9.12 |
| Price-to-Earnings Growth (PEG) Ratio | 1.90 | -0.77 | 0.22 | 1.48 | 0.51 |
| Enterprise Value Multiple | 10.95 | 11.31 | 10.13 | 12.55 | 11.67 |
| Enterprise Value | 7.24B | 7.76B | 8.93B | 8.16B | 7.33B |
| EV to EBITDA | 10.95 | 11.31 | 10.13 | 12.55 | 11.67 |
| EV to Sales | 1.00 | 1.04 | 1.20 | 1.06 | 0.99 |
| EV to Free Cash Flow | 12.54 | 16.95 | 24.20 | 16.09 | 15.21 |
| EV to Operating Cash Flow | 11.88 | 15.71 | 22.55 | 15.33 | 14.15 |
| Tangible Book Value Per Share | -47.62 | -40.98 | -36.91 | -40.07 | -41.94 |
| Shareholders’ Equity Per Share | 32.40 | 31.48 | 33.62 | 30.63 | 28.11 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.05 | 0.11 | 0.23 | 0.19 | 0.22 |
| Revenue Per Share | 156.85 | 149.28 | 140.19 | 139.31 | 128.37 |
| Net Income Per Share | 7.73 | 7.23 | 8.98 | 5.42 | 4.81 |
| Tax Burden | 0.95 | 0.89 | 0.77 | 0.80 | 0.77 |
| Interest Burden | 0.74 | 0.74 | 0.84 | 0.76 | 0.77 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.05 | 0.04 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.70 | 1.36 | 0.83 | 1.76 | 1.86 |
Currency in USD